BioSyent, Inc. (BIOYF)
9.30
-0.02
(-0.21%)
USD |
OTCM |
Jan 16, 16:00
BioSyent Market Cap: 104.74M for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Oncolytics Biotech, Inc. | 108.68M |
| Aurinia Pharmaceuticals, Inc. | 1.958B |
| Edesa Biotech, Inc. | 10.26M |
| Lexaria Bioscience Corp. | 18.88M |
| Xenon Pharmaceuticals, Inc. | 3.089B |
Market Cap Related Metrics
| PE Ratio | 17.26 |
| PS Ratio | 3.529 |
| PEG Ratio | 0.7921 |
| Price to Book Value | 3.652 |
| Price to Free Cash Flow | 18.38 |
| Price | 9.30 |
| Earnings Yield | 5.79% |
| PEGY Ratio | 0.7402 |
| Operating PE Ratio | 13.71 |
| Normalized PE Ratio | 17.26 |